IP Library Assignment 018552/0654
Patent Assignment
Reel/Frame 018552/0654

Assignment of Promissory Notes and Warrents

Recorded: 2006-11-29 Pages: 5
Assignor
BAYLOR COLLEGE OF MEDICINE
Executed: 2004-01-30
Assignee
BERGAN, RONALD
326 10TH AVE. S., FARGO, NORTH DAKOTA, 58103
Covered Properties (18)
Administration of Nucleic Acid Sequence to Female Animal to Enhance Growth in Offspring
Super-Active Porcine Growth Hormone Releasing Hormone Analog
Patent: 6,551,996 →
Application: 09/624,268 →
Administration of nucleic acid sequence to female animal to enhance growth in offspring
Application: 10/021,403 →
Publication: US 2003/0074679
Protease resistant ti-growth hormone releasing hormone
Application: 10/166,356 →
Publication: US 2004/0192593
Polynucleotides Encoding a Super-Active Porcine Growth Hormone Releasing Hormone Analog
Patent: 7,166,461 →
Application: 10/262,141 →
Publication: US 2003/0129172
Super-active porcine growth hormone releasing hormone analog
Application: 10/262,377 →
Publication: US 2003/0148948
Treating Anemia in Subjects by Administration of Plasmids Encoding Growth Hormone Releasing Hormone
Patent: 7,241,744 →
Application: 10/315,907 →
Publication: US 2004/0057941
Modified Pituitary Gland Development in Offspring from Expectant Mother Animals Treated with Growth Hormone Releasing Hormone Therapy
Patent: 7,250,405 →
Application: 10/359,919 →
Publication: US 2004/0038918
Electrode Assembly for Constant-Current Electroporation and Use
Patent: 7,245,963 →
Application: 10/360,768 →
Publication: US 2004/0167458
Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system
Application: 10/395,709 →
Publication: US 2004/0014645
Codon Optimized Synthetic Plasmids
Patent: 7,316,925 →
Application: 10/619,939 →
Publication: US 2004/0092009
Constant Current Electroporation Device and Methods of Use
Patent: 8,209,006 →
Application: 10/657,725 →
Publication: US 2005/0052630
Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
Application: 60/423,536 →
Reducing culling in herd animals growth hormone releasing hormone (GHRH)
Application: 60/443,104 →
Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
Application: 60/454,079 →
Plasmid mediated GHRH supplementation for renal failures
Application: 60/464,266 →
Devices and methods for biomaterial production
Application: 60/474,749 →
Canine-specific growth hormone releasing hormone
Application: 60/492,427 →
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 20, 2005
From: ADVISYS, INC.
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 016115/0925 →
Assignment of Promissory Notes and Warrants Nov 29, 2006
From: MCMINN, WILLIAM A.
To: BERGAN, RONALD
Reel/Frame 018552/0637 →
Assignment of Promissory Notes and Warrants Nov 29, 2006
From: CAIN, ESTATE OF GORDON A.
To: BERGAN, RONALD
Reel/Frame 018552/0597 →
Release of Security Interest Feb 20, 2007
From: BERGAN, RONALD
To: ADVISYS, INC.
Reel/Frame 018907/0249 →
Merger Aug 1, 2007
From: ADVISYS INC.
To: VGX PHARMACEUTICALS, INC.
Reel/Frame 019628/0144 →
Assignment of Assignor's Interest Mar 19, 2008
From: BAYLOR COLLEGE OF MEDICINE
To: VGX PHARMACEUTICALS, INC.
Reel/Frame 020674/0578 →
Assignment of Assignor's Interest Mar 19, 2008
From: BAYLOR COLLEGE OF MEDICINE
To: VGX PHARMACEUTICALS, INC.
Reel/Frame 020670/0762 →
Assignment of Assignor's Interest Mar 8, 2011
From: VGX PHARMACEUTICAL, INC.
To: VGXI, INC.
Reel/Frame 025918/0910 →
Merger and Change of Name Dec 21, 2020
From: VGX PHARMACEUTICALS, INC.; INOVIO ACQUISITION, LLC
To: VGX PHARMACEUTICALS, LLC
Reel/Frame 054704/0830 →
Merger Feb 2, 2021
From: VGX PHARMACEUTICALS, LLC
To: INOVIO PHARMACEUTICALS, INC.
Reel/Frame 055114/0843 →